Guangzhou's Huangpu district got off to a good start in 2022 with a succession of industrial and livelihood projects making construction progress.
The southern headquarters of Sirnaomics began operating on Guangzhou International Bio Island on Jan 8 for the R&D, pilot scale testing and biological information analysis of innovative medicines.
Sirnaomics is an international biopharmaceutical enterprise committed to the R&D and industrialization of innovative medicines for tumors, viral infections, fibrosis and metabolic diseases. It plays a significant role in both the Chinese and US markets.
The scientific research platform of the Guangzhou First People's Hospital began furnishing on Guangzhou International Bio Island on Jan 5 and will begin operating in May.
The 3,100-square-meter platform is able to accommodate 200 people and will be open for round-the-clock reservations. It will gather global talent to conduct pioneering research in the biomedicine and health sectors.
Moreover, construction on line 2 of the Huangpu tram has also made significant progress. It will run through Guangzhou Science City, the Guangzhou-Hong Kong Science and Technology Cooperation Park and the Guangzhou-Hong Kong Smart Manufacturing Cooperation Zone's Nan'gang area.
The construction site of Huangpu tram line 2.